Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2132464195;64196;64197 chr2:178587241;178587240;178587239chr2:179451968;179451967;179451966
N2AB1968359272;59273;59274 chr2:178587241;178587240;178587239chr2:179451968;179451967;179451966
N2A1875656491;56492;56493 chr2:178587241;178587240;178587239chr2:179451968;179451967;179451966
N2B1225937000;37001;37002 chr2:178587241;178587240;178587239chr2:179451968;179451967;179451966
Novex-11238437375;37376;37377 chr2:178587241;178587240;178587239chr2:179451968;179451967;179451966
Novex-21245137576;37577;37578 chr2:178587241;178587240;178587239chr2:179451968;179451967;179451966
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGC
  • RefSeq wild type template codon: TCG
  • Domain: Fn3-42
  • Domain position: 59
  • Structural Position: 90
  • Q(SASA): 0.2136
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/G None None 0.999 N 0.549 0.41 0.369495900351 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0
S/R None None 1.0 N 0.776 0.463 0.419713421852 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0853 likely_benign 0.0953 benign -0.527 Destabilizing 0.998 D 0.475 neutral None None None None N
S/C 0.1297 likely_benign 0.1312 benign -0.22 Destabilizing 1.0 D 0.793 deleterious N 0.485023403 None None N
S/D 0.6151 likely_pathogenic 0.6446 pathogenic -0.493 Destabilizing 0.999 D 0.638 neutral None None None None N
S/E 0.7203 likely_pathogenic 0.7182 pathogenic -0.38 Destabilizing 0.999 D 0.631 neutral None None None None N
S/F 0.2316 likely_benign 0.2696 benign -0.47 Destabilizing 1.0 D 0.83 deleterious None None None None N
S/G 0.1203 likely_benign 0.1309 benign -0.884 Destabilizing 0.999 D 0.549 neutral N 0.485566381 None None N
S/H 0.4436 ambiguous 0.4265 ambiguous -1.342 Destabilizing 1.0 D 0.811 deleterious None None None None N
S/I 0.218 likely_benign 0.2567 benign 0.344 Stabilizing 1.0 D 0.793 deleterious N 0.488377538 None None N
S/K 0.8368 likely_pathogenic 0.8337 pathogenic -0.364 Destabilizing 0.999 D 0.631 neutral None None None None N
S/L 0.1323 likely_benign 0.1547 benign 0.344 Stabilizing 1.0 D 0.711 prob.delet. None None None None N
S/M 0.2081 likely_benign 0.2305 benign 0.341 Stabilizing 1.0 D 0.807 deleterious None None None None N
S/N 0.2082 likely_benign 0.2299 benign -0.69 Destabilizing 0.999 D 0.617 neutral N 0.505843152 None None N
S/P 0.8701 likely_pathogenic 0.9238 pathogenic 0.091 Stabilizing 1.0 D 0.779 deleterious None None None None N
S/Q 0.6056 likely_pathogenic 0.5781 pathogenic -0.547 Destabilizing 1.0 D 0.747 deleterious None None None None N
S/R 0.7753 likely_pathogenic 0.7633 pathogenic -0.595 Destabilizing 1.0 D 0.776 deleterious N 0.504803002 None None N
S/T 0.0809 likely_benign 0.0885 benign -0.499 Destabilizing 0.999 D 0.522 neutral N 0.45985736 None None N
S/V 0.1807 likely_benign 0.2053 benign 0.091 Stabilizing 1.0 D 0.754 deleterious None None None None N
S/W 0.4837 ambiguous 0.5015 ambiguous -0.676 Destabilizing 1.0 D 0.833 deleterious None None None None N
S/Y 0.2503 likely_benign 0.2862 benign -0.272 Destabilizing 1.0 D 0.837 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.